-
-
The issue of the hairline needing to be transplanted is at this point really just a guess. Its a possibility that might be real as the clinical trials go on, but until the trials progress, we don't have any solid info to base this guess on. I would also think Replicel (probably Aderans as well) was aware of this possibility before starting the trials, and they most likely have come up or coming up with some way to administer these injections to recreate the hariline.
But we shall see.Comment
-
This is all just speculation guys. We don't know anything yet. I'm sorry to be the devils advocate on this one but we need to stay cool and just wait for trial results. And not just phase I trial results. Histogen had promising first trial results from phase I/II, and now they are nowhere to be heard from...
However unlike Histogen, I don't doubt the efficacy of Replicel I am more concerned about the current financial crisis since phase 3 trials are hardest to pull off because of their cost, managment needs and concers and so on..
On the other hand I always was and always will be a pessimist, so...Comment
-
Agreed. Until the end of the first quarter of 2012, when RepliCel should share the results of its first in-man (pilot) trial, no one has any real reason to celebrate the technology as a treatment for hairloss in human beings.
Much the same should be said of Histogen's H.S.C.: a rational person must wait to make any conclusions, until results are shared of their phase I/II trial.Comment
-
Mice are lucky motherf'ers. They get all hair treatments done on them, they can go back to their rat land and show off their new hair to the female mice. While we're here just reading about how successful treatments are on mice and we stay balding.Comment
-
@PatientlyWaiting; Agreed.
@HairTalk; End of the first Q2012 should be an exciting time, then! I'm sure we're all well ready to hear some good news, but should perhaps err on the side of skepticism. Hopeful, but realistic.Comment
Tweet
Comment